Woodline Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.3M | Sell |
159,623
-157,810
| -50% | -$47.8M | 0.26% | 102 |
|
|
2025
Q1 | $105M | Buy |
317,433
+8,316
| +3% | +$2.75M | 0.68% | 15 |
|
|
2024
Q4 | $95.4M | Buy |
309,117
+162,027
| +110% | +$50M | 0.64% | 16 |
|
|
2024
Q3 | $31.2M | Buy |
147,090
+8,781
| +6% | +$1.86M | 0.26% | 124 |
|
|
2024
Q2 | $38.7M | Buy |
138,309
+118,609
| +602% | +$33.2M | 0.37% | 74 |
|
|
2024
Q1 | $5.26M | Buy |
+19,700
| New | +$5.26M | 0.05% | 350 |
|
|
2023
Q2 | – | Sell |
-12,358
| Closed | -$2.99M | – | 704 |
|
|
2023
Q1 | $2.99M | Buy |
12,358
+10,779
| +683% | +$2.61M | 0.04% | 371 |
|
|
2022
Q4 | $458K | Sell |
1,579
-16,544
| -91% | -$4.8M | 0.01% | 605 |
|
|
2022
Q3 | $1.18M | Sell |
18,123
-64,053
| -78% | -$4.16M | 0.02% | 522 |
|
|
2022
Q2 | $5.88M | Buy |
+82,176
| New | +$5.88M | 0.09% | 237 |
|